Suppr超能文献

线粒体复合物II缺陷参与突变型亨廷顿蛋白N端片段所致的神经元死亡。

Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.

作者信息

Benchoua Alexandra, Trioulier Yaël, Zala Diana, Gaillard Marie-Claude, Lefort Nathalie, Dufour Noelle, Saudou Frederic, Elalouf Jean-Marc, Hirsch Etienne, Hantraye Philippe, Déglon Nicole, Brouillet Emmanuel

机构信息

URA CEA-CNRS 2210, Service Hospitalier Frédéric Joliot, MIRCen Program, Département de Recherches Médicales, Direction des Sciences du Vivant, Commissariat à l'Energie Atomique (CEA), 91401 Orsay Cedex, France.

出版信息

Mol Biol Cell. 2006 Apr;17(4):1652-63. doi: 10.1091/mbc.e05-07-0607. Epub 2006 Feb 1.

Abstract

Alterations of mitochondrial function may play a central role in neuronal death in Huntington's disease (HD). However, the molecular mechanisms underlying such functional deficits of mitochondria are not elucidated yet. We herein showed that the expression of two important constituents of mitochondrial complex II, the 30-kDa iron-sulfur (Ip) subunit and the 70-kDa FAD (Fp) subunit, was preferentially decreased in the striatum of HD patients compared with controls. We also examined several mitochondrial proteins in striatal neurons that were infected with lentiviral vectors coding for the N-terminus part of huntingtin (Htt) with either a pathological (Htt171-82Q) or physiological (Htt171-19Q) polyglutamine tract. Compared with Htt171-19Q, expression of Htt171-82Q preferentially decreased the levels of Ip and Fp subunits and affected the dehydrogenase activity of the complex. The Htt171-82Q-induced preferential loss of complex II was not associated with a decrease in mRNA levels, suggesting the involvement of a posttranscriptional mechanism. Importantly, the overexpression of either Ip or Fp subunit restored complex II levels and blocked mitochondrial dysfunction and striatal cell death induced by Htt171-82Q in striatal neurons. The present results strongly suggest that complex II defects in HD may be instrumental in striatal cell death.

摘要

线粒体功能改变可能在亨廷顿舞蹈病(HD)的神经元死亡中起核心作用。然而,线粒体这种功能缺陷背后的分子机制尚未阐明。我们在此表明,与对照组相比,HD患者纹状体中线粒体复合物II的两个重要组成部分,即30 kDa铁硫(Ip)亚基和70 kDa FAD(Fp)亚基的表达优先降低。我们还检测了纹状体神经元中的几种线粒体蛋白,这些神经元被编码亨廷顿蛋白(Htt)N端部分的慢病毒载体感染,该载体带有病理性(Htt171 - 82Q)或生理性(Htt171 - 19Q)的聚谷氨酰胺序列。与Htt171 - 19Q相比,Htt171 - 82Q的表达优先降低了Ip和Fp亚基的水平,并影响了该复合物的脱氢酶活性。Htt171 - 82Q诱导的复合物II优先缺失与mRNA水平降低无关,提示存在转录后机制。重要的是,Ip或Fp亚基之一的过表达恢复了复合物II的水平,并阻断了Htt171 - 82Q在纹状体神经元中诱导的线粒体功能障碍和纹状体细胞死亡。目前的结果强烈表明,HD中的复合物II缺陷可能在纹状体细胞死亡中起作用。

相似文献

1
Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.
Mol Biol Cell. 2006 Apr;17(4):1652-63. doi: 10.1091/mbc.e05-07-0607. Epub 2006 Feb 1.
9
Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease.
Mol Ther. 2007 May;15(5):903-11. doi: 10.1038/mt.sj.6300141. Epub 2007 Mar 20.
10
Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin.
J Biol Chem. 2005 Sep 2;280(35):30773-82. doi: 10.1074/jbc.M504749200. Epub 2005 Jun 27.

引用本文的文献

1
The Role of MicroRNAs in Neurodegeneration: Insights from Huntington's Disease.
Mol Neurobiol. 2025 Feb 26. doi: 10.1007/s12035-025-04750-7.
3
SIRT3-Mediated Deacetylation of SDHA Rescues Mitochondrial Bioenergetics Contributing to Neuroprotection in Rotenone-Induced PD Models.
Mol Neurobiol. 2024 Jul;61(7):4402-4420. doi: 10.1007/s12035-023-03830-w. Epub 2023 Dec 13.
4
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases.
Front Physiol. 2023 Nov 2;14:1263420. doi: 10.3389/fphys.2023.1263420. eCollection 2023.
5
The multifaceted role of quercetin derived from its mitochondrial mechanism.
Mol Cell Biochem. 2024 Aug;479(8):1985-1997. doi: 10.1007/s11010-023-04833-w. Epub 2023 Sep 1.
6
Complex II Biology in Aging, Health, and Disease.
Antioxidants (Basel). 2023 Jul 24;12(7):1477. doi: 10.3390/antiox12071477.
9
Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders.
J Cereb Blood Flow Metab. 2023 Jan;43(1):26-43. doi: 10.1177/0271678X221135061. Epub 2022 Oct 24.
10
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
Transl Neurodegener. 2022 Jul 4;11(1):36. doi: 10.1186/s40035-022-00308-y.

本文引用的文献

2
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
Science. 2005 Sep 9;309(5741):1732-5. doi: 10.1126/science.1114297.
3
Role of molecular chaperones in neurodegenerative disorders.
Int J Hyperthermia. 2005 Aug;21(5):403-19. doi: 10.1080/02656730500041871.
5
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.
Neuron. 2005 Jul 7;47(1):29-41. doi: 10.1016/j.neuron.2005.06.005.
6
p53 in neuronal apoptosis.
Biochem Biophys Res Commun. 2005 Jun 10;331(3):761-77. doi: 10.1016/j.bbrc.2005.03.149.
7
Identification of a putative p53 binding sequence within the human mitochondrial genome.
FEBS Lett. 2004 Dec 3;578(1-2):198-202. doi: 10.1016/j.febslet.2004.10.099.
8
Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia.
J Cereb Blood Flow Metab. 2004 Nov;24(11):1272-9. doi: 10.1097/01.WCB.0000140272.54583.FB.
10
Huntingtin and its role in neuronal degeneration.
Neuroscientist. 2004 Oct;10(5):467-75. doi: 10.1177/1073858404266777.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验